Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
OA-20 A New Circulating Tumor Cell-Based Prognostic System To Refine Patient Stratification Status of Newly Diagnosed Multiple Myeloma Patients — Ioannis V. Kostopoulos (2024) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
OA-20 A New Circulating Tumor Cell-Based Prognostic System To Refine Patient Stratification Status of Newly Diagnosed Multiple Myeloma Patients
Shared by
Meletios A Dimopoulos
OA-20 A New Circulating Tumor Cell-Based Prognostic System To Refine Patient Stratification Status of Newly Diagnosed Multiple Myeloma Patients
Article
2024
en
Authors
+17 more
IK
Ioannis V. Kostopoulos
IN
Ioannis Ntanasis‐Stathopoulos
PR
Pantelis Rousakis
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2025
Circulating tumor cells (CTCs) combined with frailty index offer an improved stratification system for transplant-ineligible newly diagnosed multiple myeloma patients
Ioannis V. Kostopoulos
,
Ioannis Ntanasis‐Stathopoulos
,
Panagiotis Malandrakis
,
Pantelis Rousakis
,
Nikolaos Tsakirakis
,
Evangelos Eleutherakis‐Papaiakovou
,
Nikolaos Angelis
,
Vasiliki Spiliopoulou
,
Chrysanthi Panteli
,
Rodanthi Syrigou
,
Panagiotis Bakouros
,
Eirini Solia
,
Georgia Dimitrakopoulou
,
Despina Fotiou
,
Magdalini Migkou
,
Nikolaos Kanellias
,
Maria Gavriatopoulou
,
Efstathios Kastritis
,
Ourania Tsitsilonis
,
Meletios A Dimopoulos
,
Evangelos Terpos
Letter
2022
Circulating Plasma Cells in Newly Diagnosed Multiple Myeloma: Prognostic and More
Ioannis V. Kostopoulos
,
Ioannis Ntanasis‐Stathopoulos
,
Pantelis Rousakis
,
Evangelos Eleutherakis‐Papaiakovou
,
Chrysanthi Panteli
,
Panagiotis Malandrakis
,
Nikolaos Angelis
,
Nikolaos Kanellias
,
Nikolaos Orologas‐Stavrou
,
Aristina Papanota
,
Despina Fotiou
,
Magdalini Migkou
,
Maria Gavriatopoulou
,
Efstathios Kastritis
,
Ourania Tsitsilonis
,
Evangelos Terpos
,
Meletios A Dimopoulos
Article
2023
OA-13 Increased levels of circulating tumor cells correlate with adverse clinical outcomes and distinct biological features in newly diagnosed patients with multiple myeloma
Chrysanthi Panteli
,
Evangelos Eleutherakis‐Papaiakovou
,
Nikolaos Angelis
,
Vassiliki Spiliopoulou
,
Rodanthi‐Eleni Syrigou
,
Georgia Dimitrakopoulou
,
Despina Fotiou
,
Magdalini Migkou
,
Maria Gavriatopoulou
,
Efstathios Kastritis
,
Meletios A Dimopoulos
,
Ourania Tsitsilonis
,
Evangelos Terpos
,
Ioannis V. Kostopoulos
,
Ioannis Ntanasis‐Stathopoulos
,
Pantelis Rousakis
,
Panagiotis Malandrakis
Article
2024
Outcomes of Newly Diagnosed Multiple Myeloma Patients Requiring Dialysis
Despina Fotiou
,
Foteini Theodorakakou
,
Eirini Solia
,
Maria Gavriatopoulou
,
Vasiliki Spiliopoulou
,
Ioannis Ntanasis‐Stathopoulos
,
Panagiotis Malandrakis
,
Erasmia Psimenou
,
Nikolaos Kanellias
,
Μαρία Ρούσσου
,
Magdalini Migkou
,
Evangelos Eleutherakis‐Papaiakovou
,
Evangelos Terpos
,
Meletios A Dimopoulos
,
Efstathios Kastritis
Article
2024
P-356 Prognostic Impact of t(11; 14) in Newly Diagnosed Patients With Multiple Myeloma
Ioannis Ntanasis-Stathopoulos
,
Evangelos Terpos
,
Αlexandros Briasoulis
,
Panagiotis Malandrakis
,
Despina Fotiou
,
Magdalini Migkou
,
Vasiliki Spiliopoulou
,
Foteini Theodorakakou
,
Charalampos Filippatos
,
Μαρία Ρούσσου
,
Nikolaos Kanellias
,
Evangelos Eleftherakis-Papaiakovou
,
Efstathios Kastritis
,
Meletios A Dimopoulos
,
Maria Gavriatopoulou
Discussion(0)
No comments yet. Be the first to comment.